M. Sßahin et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 103 (2013) 400–408
401
ligands as well as the fluorescence behavior of metal complexes.
We also focus on the study of the chelating properties of such li-
gands based on elemental analyses and spectral methods (FT-IR,
1H NMR, 13C NMR, ESR, UV–Vis). The biological activities of the
asymmetric Schiff bases and their metal complexes are reported
and compared with a reference standard antibiotic drug.
7.75 (d, J 7.5 Hz, 1H, HAr), 7.82 (d, J 9.0 Hz, 1H, HAr), 8.16 (d, J
8.5 Hz, 1H, HAr) 9.42 (s, 1H, CH@N), 15.32 (s, 1H, OH).
13C NMR (400 MHz, CDCl3) HL1: d 165.39, 157.04, 140.36,
135.516, 134.25, 132.84, 129.29, 128.01, 127.62, 123.56, 120.48,
119.26, 119.06, 118.99, 118.78, 116.03, 109.63.
13C NMR (400 MHz, CDCl3) HL2: d 21.25, 109.60, 116.69, 118.44,
119.26, 119.91, 120.56, 123.50, 127.58, 127.91, 129.29, 131.72,
132.82, 135.31, 138.13, 140.19, 155.09, 165.42.
Experimental
General procedure for synthesis of asymmetrical Schiff base ligands
(HL1A and HL2A)
Chemicals and apparatus
Asymmetrical Schiff base ligands HL1A and HL2A, were synthe-
sized in a similar method. A solution of HL1 (1 mmol, 0.262 g) and
HL2 (1 mmol, 0.276 g) in 30 mL chloroform/methanol (2/3, v/v)
was added dropwise to a solution 9-anthracenecarboxaldehyde
(1 mmol, 0.206 g) in 30 mL chloroform/methanol (2/3, v/v). Stirring
was continued for 3 h at room temperature during which a yellow
and orange solid compound separated. It was filtered, washed with
methanol, recrystallized from dichloromethane/methanol and
dried in vacuum.
1,2-Phenylenediamine, 4-methyl-1,2-phenylenediamine, 2-hy-
droxy-1-napthaldehyde, 9-anthracenecarboxaldehyde, ethyl alco-
hol, metal salt (Zn(OAc)2ꢀ2H2O, Ni(OAc)2ꢀ4H2O, Cu(OAc)2ꢀH2O and
Pb(OAc)2) and other chemicals used in this study were obtained Flu-
ka, Sigma–Aldrich and Merck Companies. All aqueous solutions
were prepared with deionized water which is purified with Milli-
pore Milli-Q Plus water purification system.
Elemental analyses (C, H, N) were performed using a LECO CHNS
932 (Inonu University, Malatya, Turkey) elemental analyzer. The
FT-IR spectra were recorded in the 4000–400 cmꢁ1 region, on a
Perkin Elmer Spectrum 100/ATR Sampling Accessory. The 1H
NMR and 13C NMR spectra were recorded on a Varian 400 MHz
spectrometer. Melting points were measured using a Buchi SMP-
20 melting point apparatus. Magnetic susceptibilities of metal
complex were determined using a Sheerwood Scientific MX Gouy
magnetic susceptibility apparatus and magnetic measurements
were carried out at room temperature (25 °C) using the Gouy
method with Hg[Co(SCN)4] as calibrant and diamagnetic correc-
tions were calculated from Pascal’s constants [11]. The effective
1H NMR (400 MHz, CDCl3) HL1A: d 6.95 (d, J 9.4 Hz, 1H, HAr),
7.16 (d, J 9.26 Hz, 1H, HAr), 7.20–7.23 (m, 2H, HAr), 7.38–7.39 (m,
2H, HAr), 7.46–7.52 (m, 4H, HAr) 7.66–7.84 (m, 4H, HAr), 8.04 (d, J
9.4 Hz, 2H, HAr), 8.57 (s, 1H, CH = N), 9.00 (d, J 9.0 Hz, 2H, HAr),
9.45 (d, J 12.0 Hz, 1H HAr), 9.82(s, 1H, CHANH), 11.53 (s, 1H,
CH@N), 15.06 (s, 1H, OH), 15.39 (s, 1H, CHANH).
1H NMR (400 MHz, CDCl3) HL2A: d 2.50 (s, 3H, CH3), 6.64 (s, 1H,
HAr), 6.93 (d, J 9.0 Hz, 1H, HAr), 7.16–7.20 (m, 2H, HAr), 7.28–7.32
(m, 1H, HAr), 7.48–7.56 (m, 4H, HAr), 7.64–7.72 (m, 2H, HAr),
7.76–7.80 (m, 2H, HAr), 8.03 (d, J 8.6 Hz, 2H, HAr), 8.57 (s, 1H,
CH = N), 8.99 (d, J 9.2 Hz, 2H, HAr), 9.39–9.47 (m, 1H, HAr), 9.80(d,
J 7.0 Hz, 1H, CHANH), 11.53 (s, 1H, CH@N), 15.09 (s, 1H, OH),
15.43(bs, 1H, CHANH).
magnetic moments,
the equation:
l
eff, per metal atom were calculated from
p
l
eff = 2.84 XMT BM, where XM is the molar suscepti-
bility. These synthesized materials were dried in vacuum drying
ovens marked as Vacucell 22. Ground state absorptions for the li-
gand and the complexes were made with a Perkin–Elmer Lambda
25 (UV–Vis) spectrophotometer. Perkin–Elmer LS55 Floresance
Spectrometer model was used for the steady state fluorescence
measurements of the complexes and Schiff base ligand at room
temperature (25 °C). The solutions of the ligand and complexes
were prepared in methanol medium. The XRD powder pattern
was recorded on a Bruker D.8 advance diffractometer, Sample
was scanned between 10° and 100° (2h) at 25 °C. ESR spectra of
Cu(II) complexes were recorded on a JEOL JESFA-300 X-band ESR
spectrometer with 100 kHz field modulation.
13C NMR (400 MHz, CDCl3) HL1A: d 173.66, 160.90, 168.96,
156.06, 153.93, 137.92, 137.28, 136.62, 133.56, 133.16, 131.69,
131.30, 131.09, 129.36, 129.19, 129.08, 128.03, 127.91, 127.73,
127.37, 127.26, 126.94, 125.47, 124.87, 123.58, 123.28, 122.06,
119.73, 119.60, 119.08, 118.99, 118.75, 108.85.
13C NMR (400 MHz, CDCl3) HL2A: d 173.48, 160.66, 153.67,
145.00, 137.38, 137.08, 135.23, 133.58, 131.47, 131.31, 131.08,
131.05, 129.14, 129.07, 127.86, 127.81, 127.69, 127.65, 127.54,
126.83, 125.46, 124.94, 124.90, 123.95, 123.64, 123.21, 123.12,
120.26, 120.08, 119.59, 119.35, 118.99, 118.70, 108.72, 21.26.
General procedure for synthesis of Zn(II), Ni(II), Cu(II) and Pb(II)
complexes
Synthesis
The Zn(II), Ni(II), Cu(II) and Pb(II) complexes were synthesised
by refluxing a methanolic solution of asymmetrical Schiff base li-
gands and M(II) acetate hydrate. The reaction was continued for
2 h during which a precipitate separated. It was filtered, washed
with methanol and dried in vacuum.
Synthesis of the tridentate Schiff base ligands (HL1 and HL2)
2-Hydroxy-1-napthaldehyde (1 mmol, 0.172 g) was dissolved in
30 mL mixture of chloroform/ethanol (2/3, v/v). The solution of
2-hydroxy-1-napthaldehyde was added to a solution of 1,2-phe-
nylendiamine (1.2 mmol, 0.130 g) and 4-methyl-1,2-phenylenedi-
amine(1 mmol, 0.122 g) dissolved in 20 mL ethanol. After
complete addition, the solution was stirred at ꢁ5 °C for 4 h. After
stirring the solvent was removed by rotary evaporation under re-
duced pressure. The resulting orange or dark yellow solid was col-
lected, washed with water and then recrystallized from methanol
and dried in vacuum.
Determination of antibacterial activities
The minimal inhibitory concentration (MIC) were determined
by broth microdilution methods according to CLSI (Clinical and
Laboratory Standarts Instıtute) guidelines (2009) in MHB (Becton
Dickinson, Sparks, MD) with an inoculum of approximately
5 ꢂ 105 colony-forming units (CFU)/mL (37). The invitro antibacte-
rial activity of the complexes was evaluated against standart
strains; Staphylococcus aureus ATCC (American Type Culture
Collection) 29213, S. aureus ATCC 25923, Streptococcus mutans
RSHM 676, Enterococcus faecalis ATCC 29212, Escherichia coli ATCC
25922, Pseudomonas aeruginosa ATCC 27853. The antibacterial
activity was performed in Mueller–Hinton broth (MHB) (Becton
Dickinson, Sparks, MD). All the synthesized complexes were
1H NMR (400 MHz, CDCl3) HL1: d 6.80–6.87 (m, 2H, HAr), 7.10–
7.19 (m, 3H, HAr), 7.36 (t, J 7.5 Hz, 1H, HAr), 7.53 (t, J 7.7 Hz, 1H,
HAr), 7.76 (d, J 7.9 Hz 1H, HAr), 7.83 (d, J 9.0 Hz, 1H, HAr), 8.16 (d,
J 8.5 Hz, 1H, HAr) 9.42 (s, 1H, CH@N), 15.32 (s, 1H, OH).
1H NMR (400 MHz, CDCl3) HL2: d 2.31 (s, 3H, CH3), 6.64 (s, 1H,
HAr), 6.74 (d, J 7.9 Hz, 1H, HAr), 7.08 (d, J 7.9 Hz, 1H, HAr), 7.16 (d, J
9.0 Hz, 1H, HAr), 7.33–7.38 (m, 1H, HAr), 7.50–7.55 (m, 1H, HAr),